杨志成;郭素娟;陈爱伦;王南松;
YANG Zhicheng;GUO Sujuan;CHEN Ailun;WANG Nansong;Department of Pharmacy,The University of Hong Kong-Shenzhen Hospital;Department of Respiratory and Critical Care Medicine,The University of Hong Kong-Shenzhen Hospital;

• 1:香港大学深圳医院药学部
• 2:香港大学深圳医院呼吸与危重症医学科

摘要(Abstract)：

目的为新型冠状病毒肺炎流行期间哮喘患者的药物治疗及患者管理提供建议,减少患者急性加重风险。方法临床药师参与哮喘门诊工作,为患者制定哮喘行动计划,对新冠疫情期间哮喘患者药物使用和患者管理提供建议。结果临床药师参与的哮喘门诊团队诊疗模式可以协助患者优化治疗方案,强化自我管理,减少患者发生哮喘急性加重的风险。结论临床药师参与哮喘患者的慢病管理过程,能够提高患者自我管理能力,降低患者因疫情出现哮喘控制波动的风险。
OBJECTIVE To provide recommendations for drug treatment and patient management of patients with asthma during the epidemic of Novel Coronavirus Pneumonia(COVID-19) to reduce the risk of acute exacerbations. METHODS Clinical pharmacists participated in the asthma clinic,developed an asthma action plan for patients,and provided advice on medication and patient management during the COVID-19 epidemic. RESULTS The asthma clinic team with clinical pharmacist participation could help patients optimize treatment plans,strengthen self-management,and reduce the risk of acute exacerbation of asthma. CONCLUSION The participation of clinical pharmacists in the chronic disease management process of asthma patients can further improve patients' self-management ability,and also reduce the risk of patients with asthma control fluctuations due to the epidemic.

关键词(KeyWords)： 新型冠状病毒肺炎;哮喘管理;药师门诊;哮喘行动计划;慢病管理
COVID-19;asthma management;pharmacy clinic;asthma action plan;chronic disease management

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 杨志成;郭素娟;陈爱伦;王南松;
YANG Zhicheng;GUO Sujuan;CHEN Ailun;WANG Nansong;Department of Pharmacy,The University of Hong Kong-Shenzhen Hospital;Department of Respiratory and Critical Care Medicine,The University of Hong Kong-Shenzhen Hospital;

Email:

DOI:

参考文献(References)：

• [1] Jackson D J,Johnston S L.The role of viruses in acute exacerbations of asthma[J].J Allergy ClinImmunol,2010,125(6):1178-1187.
• [2] Zheng X Y,Xu Y J,Guan W J,et al.Regional,age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation:a literature review[J].Arch Virol,2018,163(4):845-853.
• [3] Huang C,Wang Y,Li X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J].Lancet,2020,395(10223).
• [4] Dsc H,Zumla A.Severe Acute Respiratory Syndrome:Historical,Epidemiologic,and Clinical Features.Infect Dis Clin North Am.2019.33(4):869-889.
• [5] Global Initiative for Asthma.Global Strategy for asthma management and prevention [EB/OL].Updated 2020.(Assessed 2020,at www.ginasthma.com)
• [6] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2016年版).中华结核和呼吸杂志,2016,39(9).
• [7] Handforth J,Friedland J S,Sharland M.Inhaled corticosteroids after respiratory syncytial virus infection[J].BMJ,2009,338:164.
• [8] McKeever T,Mortimer K,Wilson A,et al.Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations[J].N Engl J Med,2018,378(10):902-910.
• [9] Edwards M R,Johnson M W,Johnston S L.Combination therapy:Synergistic suppression of virus-induced chemokines in airway epithelial cells[J].Am J Respir Cell Mol Biol,2006,34(5):616-624.
• [10] Weiss K B,Gern J E,Johnston N W,et al.The Back to School asthma study:the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year[J].Ann Allergy Asthma Immunol,2010,105(2):174-181.
• [11] Price D B,Hernandez D,Magyar P,et al.Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma[J].Thorax,2003,58(3):211-216.
• [12] 北京市卫生健康委员会.北京市医疗保障局关于新型冠状病毒感染的肺炎疫情期间门诊开药有关问题的通知 [EB/OL].http://www.beijing.gov.cn/zfxxgk/110088/yzyg52/2020-02/05/content_eb3de51b620548a7857cc546b77a3bde.shtml.
• [13] Dumas O,Wiley A S,Quinot C,et al.Occupational exposure to disinfectants and asthma control in US nurses[J].Eur Respir J,2017,50(4):1700237.
• [14] Siracusa A,De Blay F,Folletti I,et al.Asthma and exposure to cleaning products - a European Academy of Allergy and Clinical Immunology task force consensus statement[J].Allergy,2013,68(12):1532-1545.
• [15] 国家卫健委,国家中医药管理局.新型冠状病毒感染的肺炎诊疗方案(试行第七版)[EB/OL].2020.http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.
• [16] Ulrik C S,Backer V,Soes-Petersen U,et al.The patient's perspective:adherence or non-adherence to asthma controller therapy[J].J Asthma,2006,43(9):967-973.
• [17] Vasileiou E,Sheikh A,Butler C,et al.Effectiveness of Influenza Vaccines in Asthma:A Systematic Review and Meta-Analysis[J].Clin Infect Dis,2017,65(8):1388-1395.
• [18] Jaiwong C,Ngamphaiboon J.Effects of inactivated influenza vaccine on respiratory illnesses and asthma-related events in children with mild persistent asthma in Asia[J].Asian Pac J Allergy Immunol,2015,33(1):3-7.
• [19] Tedner S G,Lundholm C,Olsson H,et al.Depression or anxiety in adult twins is associated with asthma diagnosis but not with offspring asthma[J].Clin Exp Allergy,2016,46(6):803-812.
• [20] 中华医学会呼吸病学分会哮喘学组.支气管哮喘患者自我管理中国专家共识[J].中华结核和呼吸杂志,2018,41(3):171-178.
• [21] Cowie R L,Revitt S G,Underwood M F,et al.The effect of a peak flow-based action plan in the prevention of exacerbations of asthma[J].Chest,1997,112(6):1534-1538.
• [22] Farag H,Abd El-Wahab E W,El-Nimr N A,et al.Asthma action plan for proactive bronchial asthma self-management in adults:a randomized controlled trial[J].Int Health,2018,10(6):502-516.
• [23] 中华医学会呼吸病学分会肺功能专业组.肺功能检查指南——呼气峰值流量及其变异率检查[J].中华结核和呼吸杂志,2017,40(6):426-430.